Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Back to Agenda

Session 15: Good Clinical Practices and Quality Indicators

Session Chair(s)

JP Clement, MD

Founder and Principal

JPCC Associates, United States

This session will review Good Clinical Practices, Good Documentation Practices, training and quality, including Key Performance Indicators. In addition, personal data protection will be briefly discussed vis-à-vis HIPPAA.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 15: Good Clinical Practices and Quality Indicators

Session Chair(s)

JP Clement, MD

Be informed and stay engaged.